This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) advanced 1.52% to $2.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.73% to 51,561.93 and the NASDAQ Composite Index falling 0.09% to 26,830.96.
The stock's rise snapped a three-day losing streak.
TherapeuticsMD Inc. closed 32.20% short of its 52-week high of $2.95, which the company achieved on January 27th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 3.60% to $224.94.
Trading volume (11,769) remained 12,551 below its 50-day average volume of 24,320.
Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-04-26 1731ET

TXMD

TherapeuticsMD Inc. (TXMD) shares rose 1.52% to $2.00 on Thursday, ending a three-day losing streak. However, the stock underperformed compared to competitors like AbbVie, which gained 3.60%. Trading volume was significantly below the 50-day average. The stock remains 32.20% short of its 52-week high of $2.95 set in January.

MarketWatch Automated

Therapeutics MD

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains